Tykerb FDA Approved Drugs
TYKERB [Lapatinib DitosylateC29H26ClFN4O4S2C7H8O3SH2O]
RX
- eq 250mg base (oral tablet)
Novartis Pharms CorpMar 13, 2007
- Treatment of patients with advanced or metastatic breast cancer whose tumors overexpress her2 and who have received prior therapy including anthracycline, a taxane and trastuzumab.
- Treatment of patients with breast cancer whose tumors overexpress the her2 receptor.
WARNING: Consult a licensed physician in the appropriate field for medical treatment and drug prescription. Do not self medicate.